The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.

Clicks: 326
ID: 58916
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #23 of 44 articles by views in the journal of clinical endocrinology and metabolism

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Weight loss is strongly recommended for overweight and obese adults with type 2 diabetes. Unintentional weight loss is associated with increased risk of all-cause mortality, but few studies have examined its association with cardiovascular outcomes in patients with diabetes.To evaluate 2-year weight change and subsequent risk of cardiovascular events and mortality in established type 2 diabetes.ADVANCE was an international, multisite 2x2 factorial trial of intensive glucose control and blood pressure control. We examined 5 categories of 2-year weight change: >10% loss, 4-10% loss, stable (± <4%), 4-10% gain, >10% gain. We used Cox regression with follow-up time starting at 2 years, adjusting for intervention arm, demographics, cardiovascular risk factors, and diabetes medication use from the 2-year visit.Among 10,081 participants with valid weight measurements, average age was 66 years. By the 2-year exam, 4.3% had >10% weight loss, 18.4% had 4-10% weight loss, and 5.3% had >10% weight gain. Over the following 3 years of the trial >10% weight loss was strongly associated with major macrovascular events (HR 1.75, 95% CI: 1.26, 2.44), cardiovascular mortality (HR 2.76, 1.87, 4.09), all-cause mortality (HR 2.79, 2.10, 3.79), but not major microvascular events (HR 0.91, 0.61, 1.36), compared to stable weight. There was no evidence of effect modification by baseline BMI, age, or type of diabetes medication.In the absence of substantial lifestyle changes, weight loss may be a warning sign of poor health meriting further work-up in patients with type 2 diabetes.
Reference Key
lee2019thethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lee, Alexandra K;Woodward, Mark;Wang, Dan;Ohkuma, Toshiaki;Warren, Bethany;Sharrett, A Richey;Williams, Bryan;Marre, Michel;Hamet, Pavel;Harrap, Stephen;McEvoy, John W;Chalmers, John;Selvin, Elizabeth;
Journal the journal of clinical endocrinology and metabolism
Year 2019
DOI
dgz045
URL
Keywords
type 2 diabetes cardiovascular disease weight change unintentional weight loss

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.